4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-12-063575
Options or other derivatives
- Director acquired 585,152 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Waksal Harlan · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-11-16 | Grant or award : show line 1 in the form Common Stock Options | +420,000 | $0.17 | 2022-11-16 | 420,000 | 2,122,330 | D |
| 2012-11-16 | Grant or award : show line 2 in the form Common Stock Options | +165,152 | $0.17 | 2022-11-16 | 165,152 | 2,287,482 | D |
Loading xslF345X03/form454581_20121116051858-.xml…